SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 75263.
  • 2
    Shoenfeld Y. Systemic antiphospholipid syndrome. Lupus 2003; 12: 4978.
  • 3
    AshersonRA, CerveraR, PietteJC, ShoenfeldY, editors. The antiphospholipid syndrome II. Amsterdam: Elsevier science; 2002.
  • 4
    Ravelli A, Martini A. Antiphospholipid antibody syndrome in pediatric patients. Rheum Dis Clin North Am 1997; 23: 65776.
  • 5
    Avcin T, Cimaz R, Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 2002; 11: 410.
  • 6
    Gattorno M, Falcini F, Ravelli A, Zulian F, Buoncompagni A, Martini G, et al. Outcome of primary antiphospholipid syndrome in childhood. Lupus 2003; 12: 44953.
  • 7
    Von Scheven E, Athreya BH, Rose CD, Goldsmith DP, Morton L. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr 1996; 129: 33945.
  • 8
    Lee T, von Scheven E, Sandborg C. Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents. Curr Opin Rheumatol 2001; 13: 41521.
  • 9
    Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al, and the Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 101927.
  • 10
    Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 130911.
  • 11
    Harris EN, Gharavi AE, Patel SP, Hughes GR. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 21522.
  • 12
    Brandt JT, Barna LK, Triplett DA, and the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. Thromb Haemost 1995; 74: 1597603.
  • 13
    Krnic-Barrie S, O'Connor CR, Looney SW, Pierangeli SS, Harris EN. A retrospective review of 61 patients with antiphospholipid syndrome: analysis of factors influencing recurrent thrombosis. Arch Intern Med 1997; 157: 21018.
  • 14
    Berkun Y, Elami A, Meir K, Mevorach D, Naparstek Y. Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg 2004; 127: 41420.
  • 15
    Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jiminez S, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998; 57: 4569.
  • 16
    Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989; 68: 35365.
  • 17
    Kenet G, Waldman D, Lubetsky A, Kornbrut N, Khalil A, Koren A, et al. Paediatric cerebral sinus vein thrombosis: a multi-center, case-controlled study. Thromb Haemost 2004; 92: 7138.
  • 18
    Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000; 31: 12838.
  • 19
    Kenet G, Maayan-Metzger A, Rosenberg N, Sela BA, Mazkereth R, Ifrah A, et al. Thrombophilia does not increase risk for neonatal complications in preterm infants. Thromb Haemost 2003; 90: 8238.
  • 20
    Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood 2004; 104: 1438.
  • 21
    Regeczy N, Lakos G, Balogh I, Ajzner E, Kiss E, Szegedi G. The Leiden mutation of coagulation factor V in Hungarian SLE patients. Clin Appl Thromb Hemost 2000; 6: 415.
  • 22
    Fijnheer R, Horbach DA, Donders RC, Vile H, von Oort E, Nieuwenhuis HK, et al. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb Haemost 1996; 76: 5147.
  • 23
    Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994; 83: 3727.
  • 24
    Boffa MC, Aurousseau MH, Lachassinne E, Dauphin H, Fain O, le Toumelin P, et al. European register of babies born to mothers with antiphospholipid syndrome. Lupus 2004; 13: 7137.
  • 25
    Campos LM, Kiss MH, D'Amico EA, Silva CA. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus 2003; 12: 8206.
  • 26
    Khamashta MA, Shoenfeld Y. Antiphospholipid syndrome: a consensus for treatment? [editorial] Lupus 2003; 12: 495.